
    
      The study had 2 phases. In phase 1, Patients of axial Spondyloarthritis were randomized into
      2 groups; group A and group B. they were put on indomethacin 150 mg/day and indomethacin 100
      mg/day respectively and were followed up at 3rd week. Those who had normal serum creatinine
      and responded with the drug were followed up to 24th week. Those who did not respond were
      excluded from phase 1 and were enrolled in phase 2. Non-responders of indomethacin 150mg and
      indomethacin 100 mg were put on etoricoxib 90 mg and etoricoxib 60 mg respectively. Again
      followed up to 24th week.
    
  